UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of immunology (1950), ISSN 0022-1767, 01/2004, Volume 172, Issue 1, pp. 567 - 576
Life Sciences & Biomedicine | Immunology | Science & Technology | Protein Binding - genetics | Protein Biosynthesis | Interleukin-6 - antagonists & inhibitors | Humans | Tumor Necrosis Factor-alpha - genetics | Immunoglobulins - genetics | Lipopolysaccharides - antagonists & inhibitors | RNA, Messenger - metabolism | Suppressor of Cytokine Signaling Proteins | Repressor Proteins - antagonists & inhibitors | Antigens, CD - metabolism | Trans-Activators - physiology | Protein Tyrosine Phosphatases - antagonists & inhibitors | RNA, Messenger - biosynthesis | Protein Tyrosine Phosphatases - genetics | Inflammation Mediators - physiology | Glycoproteins - genetics | DNA-Binding Proteins - physiology | Protein Tyrosine Phosphatases - biosynthesis | DNA-Binding Proteins - antagonists & inhibitors | Signal Transduction - genetics | DNA - metabolism | Down-Regulation - genetics | Macrophages - metabolism | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | Repressor Proteins - biosynthesis | Up-Regulation - immunology | Interleukin-10 - antagonists & inhibitors | Lipopolysaccharides - pharmacology | Adenoviruses, Human - genetics | Interleukin-10 - immunology | Tumor Necrosis Factor-alpha - biosynthesis | Phosphorylation | Tissue Inhibitor of Metalloproteinase-1 - biosynthesis | Antigens, CD - biosynthesis | Receptors, Cell Surface | Receptors, IgG - biosynthesis | Receptors, IgG - antagonists & inhibitors | Interleukin-10 - physiology | Signal Transduction - immunology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Signaling Lymphocytic Activation Molecule Family Member 1 | Receptors, Tumor Necrosis Factor - antagonists & inhibitors | RNA, Messenger - antagonists & inhibitors | Receptors, Tumor Necrosis Factor, Type II | Trans-Activators - genetics | Inflammation Mediators - antagonists & inhibitors | Trans-Activators - biosynthesis | Immunoglobulins - biosynthesis | Macrophages - immunology | Inflammation Mediators - immunology | Receptors, Tumor Necrosis Factor - metabolism | Immune Sera - pharmacology | Proteins - physiology | Cells, Cultured | Glycoproteins - antagonists & inhibitors | Histocompatibility Antigens Class II - biosynthesis | Tissue Inhibitor of Metalloproteinase-1 - antagonists & inhibitors | Transcription Factors - antagonists & inhibitors | Transcription Factors - biosynthesis | Up-Regulation - genetics | DNA-Binding Proteins - genetics | DNA - antagonists & inhibitors | Glycoproteins - biosynthesis | Suppressor of Cytokine Signaling 3 Protein | Down-Regulation - immunology | Interleukin-6 - biosynthesis | Receptors, Tumor Necrosis Factor - biosynthesis | STAT3 Transcription Factor | Trans-Activators - antagonists & inhibitors | Genetic Vectors | DNA-Binding Proteins - biosynthesis | Tumor Necrosis Factor-alpha - antagonists & inhibitors | SOCS-3 protein | Index Medicus | Abridged Index Medicus
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 04/2014, Volume 40, Issue 4, pp. 477 - 489
Life Sciences & Biomedicine | Immunology | Science & Technology | Myelin-Oligodendrocyte Glycoprotein - immunology | T-Lymphocyte Subsets - immunology | Transcription, Genetic - drug effects | Nuclear Receptor Subfamily 1, Group F, Member 3 - antagonists & inhibitors | Humans | Transcriptional Activation - drug effects | Encephalomyelitis, Autoimmune, Experimental - immunology | Structure-Activity Relationship | Gene Regulatory Networks - drug effects | Cell Lineage - drug effects | Systems Biology | Benzhydryl Compounds - chemistry | Heterocyclic Compounds, 4 or More Rings - pharmacology | Th17 Cells - drug effects | T-Lymphocyte Subsets - drug effects | Peptide Fragments - immunology | Protein Binding - drug effects | Benzeneacetamides - chemistry | Benzeneacetamides - pharmacology | Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics | Cytokines - metabolism | Encephalomyelitis, Autoimmune, Experimental - drug therapy | Mice, Inbred C57BL | Heterocyclic Compounds, 4 or More Rings - chemistry | Digoxin - chemistry | Digoxin - pharmacology | Mice, Knockout | Animals | Androstenols - chemistry | Cell Differentiation - drug effects | Cell Line, Tumor | Multiple Sclerosis - immunology | Th17 Cells - immunology | Benzhydryl Compounds - pharmacology | Mice | Multiple Sclerosis - drug therapy | Index Medicus
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 11/2012, Volume 61, Issue 11, pp. 2842 - 2850
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Islets of Langerhans - drug effects | Reactive Oxygen Species - metabolism | Membrane Glycoproteins - metabolism | Humans | NADPH Oxidases - metabolism | Secretory Vesicles - metabolism | Insulin-Secreting Cells - metabolism | Membrane Glycoproteins - antagonists & inhibitors | Islets of Langerhans - metabolism | Isoenzymes - metabolism | Islets of Langerhans - cytology | NADPH Oxidases - genetics | Insulin-Secreting Cells - cytology | Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors | Cyclic AMP - metabolism | Insulin Secretion | Cyclic AMP-Dependent Protein Kinases - metabolism | Second Messenger Systems - drug effects | Glucagon-Like Peptide 1 - metabolism | Isoenzymes - genetics | Tissue Culture Techniques | Mice, Inbred C57BL | NADPH Oxidases - antagonists & inhibitors | Cells, Cultured | Gene Silencing | NADPH Oxidase 2 | Membrane Glycoproteins - genetics | Mice, Knockout | Cyclic AMP - antagonists & inhibitors | Insulin - metabolism | Animals | Insulin-Secreting Cells - drug effects | Secretory Vesicles - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | RNA, Small Interfering | Cyclic AMP - agonists | Isoenzymes - antagonists & inhibitors | Oxidases | Physiological aspects | Pancreatic beta cells | Research | Analysis | NADP (Coenzyme) | Index Medicus | Abridged Index Medicus | Islet Studies
Journal Article
Cell host & microbe, ISSN 1931-3128, 07/2009, Volume 6, Issue 1, pp. 54 - 67
Parasitology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Virology | Amino Acid Sequence | Antigens, CD - immunology | Cell Line | Humans | GPI-Linked Proteins | Molecular Sequence Data | Simian Immunodeficiency Virus - growth & development | Haplorhini | Animals | Membrane Glycoproteins - antagonists & inhibitors | Membrane Glycoproteins - immunology | Gene Products, nef - immunology | Simian Immunodeficiency Virus - immunology | Virus diseases | Antiviral agents | Monkeys | Universities and colleges | Viral proteins | HIV (Viruses) | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 9/2010, Volume 329, Issue 5997, pp. 1345 - 1348
Hep G2 cells | Cytokines | REPORTS | Stem cells | Multipotent stem cells | Bone marrow | Cultured cells | Transplantation | Aryl hydrocarbon receptors | Hematopoietic stem cells | Blood | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Biological and medical sciences | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Antigens, CD34 - analysis | Cell Proliferation | Receptors, Aryl Hydrocarbon - antagonists & inhibitors | Species Specificity | Cell Count | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Antigens, CD - analysis | Multipotent Stem Cells - drug effects | Hematopoiesis | Polychlorinated Dibenzodioxins - pharmacology | Hematopoietic Stem Cells - physiology | Receptors, Aryl Hydrocarbon - metabolism | Multipotent Stem Cells - physiology | Hematopoietic Stem Cells - drug effects | Signal Transduction | Purines - metabolism | Purines - pharmacology | Cells, Cultured | Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cells - metabolism | Mice, SCID | AC133 Antigen | Aryl Hydrocarbon Hydroxylases - metabolism | Cell Lineage | Animals | Multipotent Stem Cells - cytology | Small Molecule Libraries | Hematopoietic Stem Cells - cytology | Cytochrome P-450 CYP1B1 | Mice, Inbred NOD | Mice | Glycoproteins - analysis | Cytokines - pharmacology | Peptides - analysis | Physiological aspects | Arylation | Human | Receptors | Aromatic compounds | Modulation | Hydrocarbons | Derivatives | Culture | Index Medicus
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 01/1993, Volume 268, Issue 2, pp. 1066 - 1073
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Fundamental and applied biological sciences. Psychology | Proteins | Binding and carrier proteins | Biological and medical sciences | Analytical, structural and metabolic biochemistry | Amino Acid Sequence | Oligopeptides - chemical synthesis | Disintegrins | Humans | Melanoma | Molecular Sequence Data | Peptides, Cyclic - pharmacology | Structure-Activity Relationship | Cell Adhesion - drug effects | Peptides - pharmacology | Venoms - chemical synthesis | Platelet Membrane Glycoproteins - drug effects | Peptides - chemical synthesis | Peptides, Cyclic - chemical synthesis | Platelet Membrane Glycoproteins - metabolism | Platelet Aggregation - drug effects | Venoms - pharmacology | Kinetics | Tumor Cells, Cultured | Oligopeptides - pharmacology | antagonists | specificity | barbourin | integrin | glycoprotein IIb-IIIa | design | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 03/2014, Volume 74, Issue 5, pp. 1554 - 1565
Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Pneumology | Lung Neoplasms - drug therapy | Neoplastic Stem Cells - drug effects | Humans | Lung Neoplasms - metabolism | Glycoproteins - metabolism | Peptides - genetics | Lung Neoplasms - pathology | Receptors, Neuropeptide - metabolism | Antigens, CD - genetics | Small Cell Lung Carcinoma - drug therapy | Proto-Oncogene Proteins c-akt - genetics | Antigens, CD - metabolism | Small Cell Lung Carcinoma - metabolism | Peptides - metabolism | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Neuropeptides - genetics | Proto-Oncogene Proteins c-akt - metabolism | Glycoproteins - genetics | Lung Neoplasms - genetics | Mice, Inbred C57BL | Carcinogenesis - genetics | Receptors, Neuropeptide - genetics | Neuropeptides - metabolism | Small Cell Lung Carcinoma - genetics | AC133 Antigen | Drug Resistance, Neoplasm - genetics | Small Cell Lung Carcinoma - pathology | Animals | Cell Line, Tumor | Mice | Neuropeptides - antagonists & inhibitors | Index Medicus
Journal Article
Reviews in Endocrine and Metabolic Disorders, ISSN 1389-9155, 6/2006, Volume 7, Issue 1, pp. 51 - 65
Signaling | Medicine & Public Health | Internal Medicine | Bone morphogenetic proteins | Diabetes | Osteoblasts | Wnts | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Carrier Proteins - physiology | Bone Morphogenetic Proteins - antagonists & inhibitors | Proteins - physiology | Bone and Bones - physiology | Bone Development - drug effects | Bone Morphogenetic Proteins - physiology | Humans | Smad Proteins - physiology | Glycoproteins - physiology | Intercellular Signaling Peptides and Proteins - physiology | Bone Morphogenetic Proteins - metabolism | Animals | Membrane Proteins - physiology | Protein Processing, Post-Translational | Bone Development - genetics | Bone Morphogenetic Proteins - pharmacology | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 10/2019, Volume 394, Issue 10206, pp. 1335 - 1343
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Thiazoles - therapeutic use | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Vitamin K - antagonists & inhibitors | Acute Coronary Syndrome - complications | Fibrinolytic Agents - therapeutic use | Acute Coronary Syndrome - surgery | Female | Aged | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Stents | Percutaneous Coronary Intervention | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Care and treatment | Atrial fibrillation | Analysis | Cardiac patients | Intervention | Cardiac arrhythmia | Heart attacks | Cardiovascular disease | Family medical history | Dosage | Bleeding | Randomization | Fibrillation | Electrocardiography | Safety | P-Glycoprotein | Heart diseases | Vitamin K | Creatinine | Anticoagulants | Aspirin | Stroke | Coronary artery | Glycoproteins | Coronary artery disease | Patients | Thrombosis | Inhibitors | Coronary vessels | Phylloquinone | Acute coronary syndromes | Index Medicus | Abridged Index Medicus
Journal Article